世界のヒト免疫不全ウイルス（HIV）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Human Immunodeficiency Virus (HIV) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2948 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ヒト免疫不全ウイルス（HIV）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（病院、外来手術センター、診断センター、在宅医療施設、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ヒト免疫不全ウイルス（HIV）の市場動向 ・企業の競争状況、市場シェア ・ヒト免疫不全ウイルス（HIV）の種類別市場規模（診断、治療） ・ヒト免疫不全ウイルス（HIV）の用途別市場規模（病院、外来手術センター、診断センター、在宅医療施設、その他） ・ヒト免疫不全ウイルス（HIV）の北米市場規模2016-2027（アメリカ、カナダ） ・ヒト免疫不全ウイルス（HIV）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒト免疫不全ウイルス（HIV）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒト免疫不全ウイルス（HIV）の中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒト免疫不全ウイルス（HIV）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Gilead、GlaxoSmithKline、Johnson & Johnson、Merck、AbbVie、Bristol-Myers Squibb、Boehringer Ingelheim、Genentech、Cipla） ・結論

HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person cannot get rid of this virus properly but its effects can be reduced with the treatment.
The global HIV market is expected to grow in future due to decreasing HIV related death rates, low awareness of HIV transmission and government initiatives to promote HIV treatment. Key trends of this market include progressing HIV drug under pipeline, increasing adoption of STR and Development of technologically advanced diagnostic products. However, there are some factors which can hinder growth of the market including decreasing global HIV funds, social stigma and discrimination and treatment failures.

Market Analysis and Insights: Global Human Immunodeficiency Virus (HIV) Market
The global Human Immunodeficiency Virus (HIV) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Immunodeficiency Virus (HIV) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Immunodeficiency Virus (HIV) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Immunodeficiency Virus (HIV) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Immunodeficiency Virus (HIV) market.

Global Human Immunodeficiency Virus (HIV) Scope and Market Size
Human Immunodeficiency Virus (HIV) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Immunodeficiency Virus (HIV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Diagnosis
Treatment

Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Homecare Settings
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Gilead
GlaxoSmithKline
Johnson & Johnson
Merck
AbbVie
Bristol-Myers Squibb
Boehringer Ingelheim
Genentech
Cipla

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Human Immunodeficiency Virus (HIV) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Homecare Settings
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Human Immunodeficiency Virus (HIV) Market Perspective (2016-2027)
2.2 Human Immunodeficiency Virus (HIV) Growth Trends by Regions
2.2.1 Human Immunodeficiency Virus (HIV) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Immunodeficiency Virus (HIV) Historic Market Share by Regions (2016-2021)
2.2.3 Human Immunodeficiency Virus (HIV) Forecasted Market Size by Regions (2022-2027)
2.3 Human Immunodeficiency Virus (HIV) Industry Dynamic
2.3.1 Human Immunodeficiency Virus (HIV) Market Trends
2.3.2 Human Immunodeficiency Virus (HIV) Market Drivers
2.3.3 Human Immunodeficiency Virus (HIV) Market Challenges
2.3.4 Human Immunodeficiency Virus (HIV) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Human Immunodeficiency Virus (HIV) Players by Revenue
3.1.1 Global Top Human Immunodeficiency Virus (HIV) Players by Revenue (2016-2021)
3.1.2 Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Players (2016-2021)
3.2 Global Human Immunodeficiency Virus (HIV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Immunodeficiency Virus (HIV) Revenue
3.4 Global Human Immunodeficiency Virus (HIV) Market Concentration Ratio
3.4.1 Global Human Immunodeficiency Virus (HIV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus (HIV) Revenue in 2020
3.5 Human Immunodeficiency Virus (HIV) Key Players Head office and Area Served
3.6 Key Players Human Immunodeficiency Virus (HIV) Product Solution and Service
3.7 Date of Enter into Human Immunodeficiency Virus (HIV) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Human Immunodeficiency Virus (HIV) Breakdown Data by Type
4.1 Global Human Immunodeficiency Virus (HIV) Historic Market Size by Type (2016-2021)
4.2 Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Type (2022-2027)

5 Human Immunodeficiency Virus (HIV) Breakdown Data by Application
5.1 Global Human Immunodeficiency Virus (HIV) Historic Market Size by Application (2016-2021)
5.2 Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Human Immunodeficiency Virus (HIV) Market Size (2016-2027)
6.2 North America Human Immunodeficiency Virus (HIV) Market Size by Type
6.2.1 North America Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021)
6.2.2 North America Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027)
6.2.3 North America Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2027)
6.3 North America Human Immunodeficiency Virus (HIV) Market Size by Application
6.3.1 North America Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021)
6.3.2 North America Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027)
6.3.3 North America Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2027)
6.4 North America Human Immunodeficiency Virus (HIV) Market Size by Country
6.4.1 North America Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021)
6.4.2 North America Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Human Immunodeficiency Virus (HIV) Market Size (2016-2027)
7.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Type
7.2.1 Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021)
7.2.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027)
7.2.3 Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2027)
7.3 Europe Human Immunodeficiency Virus (HIV) Market Size by Application
7.3.1 Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021)
7.3.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027)
7.3.3 Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2027)
7.4 Europe Human Immunodeficiency Virus (HIV) Market Size by Country
7.4.1 Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021)
7.4.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size (2016-2027)
8.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Type
8.2.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Application
8.3.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region
8.4.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Human Immunodeficiency Virus (HIV) Market Size (2016-2027)
9.2 Latin America Human Immunodeficiency Virus (HIV) Market Size by Type
9.2.1 Latin America Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021)
9.2.2 Latin America Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027)
9.2.3 Latin America Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2027)
9.3 Latin America Human Immunodeficiency Virus (HIV) Market Size by Application
9.3.1 Latin America Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021)
9.3.2 Latin America Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027)
9.3.3 Latin America Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2027)
9.4 Latin America Human Immunodeficiency Virus (HIV) Market Size by Country
9.4.1 Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021)
9.4.2 Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size (2016-2027)
10.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type
10.2.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application
10.3.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country
10.4.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Gilead
11.1.1 Gilead Company Details
11.1.2 Gilead Business Overview
11.1.3 Gilead Human Immunodeficiency Virus (HIV) Introduction
11.1.4 Gilead Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021)
11.1.5 Gilead Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Introduction
11.2.4 GlaxoSmithKline Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Human Immunodeficiency Virus (HIV) Introduction
11.3.4 Johnson & Johnson Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Human Immunodeficiency Virus (HIV) Introduction
11.4.4 Merck Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021)
11.4.5 Merck Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Details
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Human Immunodeficiency Virus (HIV) Introduction
11.5.4 AbbVie Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021)
11.5.5 AbbVie Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Introduction
11.6.4 Bristol-Myers Squibb Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Details
11.7.2 Boehringer Ingelheim Business Overview
11.7.3 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Introduction
11.7.4 Boehringer Ingelheim Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021)
11.7.5 Boehringer Ingelheim Recent Development
11.8 Genentech
11.8.1 Genentech Company Details
11.8.2 Genentech Business Overview
11.8.3 Genentech Human Immunodeficiency Virus (HIV) Introduction
11.8.4 Genentech Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021)
11.8.5 Genentech Recent Development
11.9 Cipla
11.9.1 Cipla Company Details
11.9.2 Cipla Business Overview
11.9.3 Cipla Human Immunodeficiency Virus (HIV) Introduction
11.9.4 Cipla Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021)
11.9.5 Cipla Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnosis
Table 3. Key Players of Treatment
Table 4. Global Human Immunodeficiency Virus (HIV) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Human Immunodeficiency Virus (HIV) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Human Immunodeficiency Virus (HIV) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Human Immunodeficiency Virus (HIV) Market Share by Regions (2016-2021)
Table 8. Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Human Immunodeficiency Virus (HIV) Market Share by Regions (2022-2027)
Table 10. Human Immunodeficiency Virus (HIV) Market Trends
Table 11. Human Immunodeficiency Virus (HIV) Market Drivers
Table 12. Human Immunodeficiency Virus (HIV) Market Challenges
Table 13. Human Immunodeficiency Virus (HIV) Market Restraints
Table 14. Global Human Immunodeficiency Virus (HIV) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Human Immunodeficiency Virus (HIV) Market Share by Players (2016-2021)
Table 16. Global Top Human Immunodeficiency Virus (HIV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immunodeficiency Virus (HIV) as of 2020)
Table 17. Ranking of Global Top Human Immunodeficiency Virus (HIV) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Human Immunodeficiency Virus (HIV) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Immunodeficiency Virus (HIV) Product Solution and Service
Table 21. Date of Enter into Human Immunodeficiency Virus (HIV) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Type (2016-2021)
Table 25. Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Human Immunodeficiency Virus (HIV) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Application (2016-2021)
Table 29. Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Gilead Company Details
Table 62. Gilead Business Overview
Table 63. Gilead Human Immunodeficiency Virus (HIV) Product
Table 64. Gilead Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million)
Table 65. Gilead Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Product
Table 69. GlaxoSmithKline Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Human Immunodeficiency Virus (HIV) Product
Table 74. Johnson & Johnson Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Human Immunodeficiency Virus (HIV) Product
Table 79. Merck Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. AbbVie Company Details
Table 82. AbbVie Business Overview
Table 83. AbbVie Human Immunodeficiency Virus (HIV) Product
Table 84. AbbVie Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million)
Table 85. AbbVie Recent Development
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Product
Table 89. Bristol-Myers Squibb Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Development
Table 91. Boehringer Ingelheim Company Details
Table 92. Boehringer Ingelheim Business Overview
Table 93. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Product
Table 94. Boehringer Ingelheim Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million)
Table 95. Boehringer Ingelheim Recent Development
Table 96. Genentech Company Details
Table 97. Genentech Business Overview
Table 98. Genentech Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million)
Table 99. Genentech Recent Development
Table 100. Cipla Company Details
Table 101. Cipla Business Overview
Table 102. Cipla Human Immunodeficiency Virus (HIV) Product
Table 103. Cipla Revenue in Human Immunodeficiency Virus (HIV) Business (2016-2021) & (US$ Million)
Table 104. Cipla Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Immunodeficiency Virus (HIV) Market Share by Type: 2020 VS 2027
Figure 2. Diagnosis Features
Figure 3. Treatment Features
Figure 4. Global Human Immunodeficiency Virus (HIV) Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Homecare Settings Case Studies
Figure 9. Others Case Studies
Figure 10. Human Immunodeficiency Virus (HIV) Report Years Considered
Figure 11. Global Human Immunodeficiency Virus (HIV) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Human Immunodeficiency Virus (HIV) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Human Immunodeficiency Virus (HIV) Market Share by Regions: 2020 VS 2027
Figure 14. Global Human Immunodeficiency Virus (HIV) Market Share by Regions (2022-2027)
Figure 15. Global Human Immunodeficiency Virus (HIV) Market Share by Players in 2020
Figure 16. Global Top Human Immunodeficiency Virus (HIV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immunodeficiency Virus (HIV) as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Human Immunodeficiency Virus (HIV) Revenue in 2020
Figure 18. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Type (2016-2021)
Figure 19. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Type (2022-2027)
Figure 20. North America Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Human Immunodeficiency Virus (HIV) Market Share by Type (2016-2027)
Figure 22. North America Human Immunodeficiency Virus (HIV) Market Share by Application (2016-2027)
Figure 23. North America Human Immunodeficiency Virus (HIV) Market Share by Country (2016-2027)
Figure 24. United States Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Human Immunodeficiency Virus (HIV) Market Share by Type (2016-2027)
Figure 28. Europe Human Immunodeficiency Virus (HIV) Market Share by Application (2016-2027)
Figure 29. Europe Human Immunodeficiency Virus (HIV) Market Share by Country (2016-2027)
Figure 30. Germany Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Share by Region (2016-2027)
Figure 40. China Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Human Immunodeficiency Virus (HIV) Market Share by Type (2016-2027)
Figure 48. Latin America Human Immunodeficiency Virus (HIV) Market Share by Application (2016-2027)
Figure 49. Latin America Human Immunodeficiency Virus (HIV) Market Share by Country (2016-2027)
Figure 50. Mexico Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Country (2016-2027)
Figure 56. Turkey Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Gilead Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021)
Figure 63. AbbVie Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021)
Figure 65. Boehringer Ingelheim Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021)
Figure 66. Genentech Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021)
Figure 67. Cipla Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---